Although most men in HICs opt for medical castration with GnRH agonists, these drugs are not more effective than orchiectomy, which is cheaper and more convenient (ie, a one-off procedure rather than semi-regular injections) and should be made available as a treatment option for everyone with advanced prostate cancer. This evidence concerns the gene GNRH1 and prostate carcinoma.